Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATAC Quality of Life Sub-study
NCT00784680Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Apr 1998
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
01
Overview
A Phase 3 trial of anastrozole in breast cancer, sponsored by AstraZeneca. Started Apr 1998; status: completed.
02
Drugs
anastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00784680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00784680.